Trustmark Corporation logo TRMK - Trustmark Corporation

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
0
BUY 0
HOLD 7
SELL 2
STRONG
SELL
0
| PRICE TARGET: $45.50 DETAILS
HIGH: $45.50
LOW: $45.50
MEDIAN: $45.50
CONSENSUS: $45.50
DOWNSIDE: 2.38%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Banks, Insurers & Asset Managers 85% confidence

Primary model: P/Tangible Book × ROE Quality

Valuation Signal Undervalued Moderate
Trading 26.6% below fair value
Current Price $46.61
Bear Case $40.18 13.8% downside ($40.18 - $46.61) / $46.61 = -13.8% ROTCE 9.4% → 1.41x TBV
Fair Value $63.49 36.2% upside ($63.49 - $46.61) / $46.61 = 36.2% ROTCE 12.5% → 2.23x TBV
Bull Case $77.48 66.2% upside ($77.48 - $46.61) / $46.61 = 66.2% ROTCE 14.4% → 2.72x TBV

Adjust Assumptions

12.5%
7.8%

Key Value Driver

ROTCE (12.5%) vs. cost of equity (7.8%)

Implied Market Multiple 1.53x

Plain-Language Summary

Our base-case estimate uses P/Tangible Book × ROE Quality. We then blend that result with the average analyst price target of $45.50 from 9 analysts, using a 20% weight on analyst consensus. That produces an estimated intrinsic value of $63.49 per share.

Warnings

Traditional cash flow models don't work well for banks — lending activity distorts how much cash the business actually generates.
Common valuation shortcuts don't apply here — for banks, interest payments are a core business cost, not overhead.
Dividend-based valuation: $15.13 (78% below our primary estimate). Large gaps suggest the dividend may not fully reflect the company's value.
Wall Street's average price target is $45.50 (from 9 analysts). Our estimate is 49% above the consensus -- consider that gap carefully.

Key Risks

  • Book value quality matters as much as level — check loan loss reserves
  • Interest rate sensitivity creates non-linear earnings surprises
  • Insurance reserving is actuarial, not financial — errors emerge slowly